Hawktail

Terrain BioSciences is in the field of RNA-based therapeutics and vaccine development. Leveraging advanced AI and proprietary manufacturing platforms, Terrain BioSciences addresses the challenges of designing, selecting, manufacturing, and delivering optimal RNA sequences. Terrain BioSciences collaborates with over a dozen biotech firms to enhance the expression, durability, and manufacturability of RNA sequences, significantly accelerating their path to clinical application. With a focus on personalized cancer vaccines and other RNA-based modalities, Terrain BioSciences is at the forefront of the next generation of programmable medicines.

ExpressionEdits is a biotechnology company focused on enhancing synthetic DNA instructions to improve protein expression. Utilizing an AI-driven research platform, the company aims to transform existing methodologies for transgene expression in mammalian systems, thereby increasing the yields, quality, and efficacy of recombinant proteins and DNA medicines. The team comprises scientists and engineers committed to advancing technologies that mimic natural biological processes. By addressing fundamental challenges in protein expression, ExpressionEdits plays a significant role in supporting research and development in healthcare and synthetic biology.

Cache is a biotechnology company focused on developing a groundbreaking wet operating system designed for the storage, access, and computation of biomolecules at scale. By ensuring the integrity and fidelity of nucleic acids from various sources, Cache enables researchers and partners to accelerate molecular pathology research and gain insights into life sciences. This innovative approach facilitates the analysis of biomolecules, thereby unlocking new precision medicine applications and enhancing the capacity for understanding biological data. Ultimately, Cache aims to make both digital and biological data universally accessible and sustainable, eliminating the need for data deletion or disposal.

OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the barriers posed by tumors. By enhancing the effectiveness and durability of immunotherapies, OverT Bio aims to advance the healthcare field's ability to identify and ultimately cure cancer.

A market leader​ ​in providing network and security solutions to enterprises.

Zafrens is a drug discovery company based in San Diego, California, founded in 2021. The company specializes in developing life sciences products that facilitate the comprehensive characterization of diverse cell populations. Its innovative platform focuses on generating insights at the intersection of biology, chemistry, and engineering. Zafrens employs a resolution approach to study interactions between cells and drugs by directly mapping the molecular states of individual cells. The extensive volume of curated experimental data generated by Zafrens is utilized to train artificial intelligence models aimed at advancing drug discovery. Additionally, the company possesses internal expertise in T cell immunotherapies and ribonucleic acid regulation, leveraging its proprietary data and experimental capabilities to support advancements in the medical industry.

Bring all of your company data together and use it with the best AI tools.

Reask is a science and technology company that specializes in natural hazard modeling and climate risk analytics. It develops software designed to connect catastrophe modeling with operational forecasting, offering solutions for real-time, post-event, and long-term assessments of weather-related risks. Utilizing machine learning and artificial intelligence, Reask provides comprehensive weather risk analysis and probabilistic trend forecasting. This enables organizations to better understand their exposure to global weather-related catastrophes and assess the risk levels within their asset portfolios. By focusing on global risk mapping and catastrophe risk analytics, Reask helps companies make informed decisions in managing their risk profiles.

Standard Fleet develops software specifically for electric fleet businesses, focusing on delivery, rental, carshare, lease, and taxi operations. The company's platform offers online and mobile tools that help clients track charging, supercharging, and trip expenses, while also generating activity and mileage reports. Additionally, it provides alerts on battery health, tire maintenance, and wear reduction, enabling users to manage their electric vehicle fleets more efficiently and profitably. Founded by a former CEO of a transportation startup acquired by Apple, Standard Fleet is backed by prominent Silicon Valley investors and comprises a team of experienced engineers and professionals from leading tech companies. The company's mission is to automate workflows, secure vehicles, and facilitate the scaling of operations for its users, with a particular emphasis on Tesla and internet-connected electric vehicles.

Gridware specializes in advanced grid monitoring solutions aimed at enhancing the safety and reliability of electrical infrastructure. The company develops a sophisticated sensing system equipped with high-precision sensor arrays and artificial intelligence to continuously analyze the electrical and mechanical behavior of grid assets. This technology detects and predicts faults by monitoring the ambient environment around power poles, allowing utilities to identify potential issues before they escalate into serious problems. By facilitating timely repairs and enabling rapid responses to environmental anomalies, Gridware's solutions help mitigate risks such as wildfires and power outages. Headquartered in the Bay Area of California, Gridware is a privately held company supported by prominent climate-tech investors.

Range Biotechnologies develops innovative tools focused on personalized health through translational proteomics. The company's technology allows for the precise measurement of multiple proteins across various samples simultaneously. This capability provides healthcare professionals with valuable insights into the fundamental mechanisms of diseases and their progression over time, ultimately advancing human health.

Modulo Bio simulates the neuroimmune system to find medication candidates that target microglia cells. The organization's proprietary neuroimmune platform combines the most recent developments in stem cell biology and neuroscience with software, automation, and artificial intelligence to create novel treatments.

DREM operates an energy-saving platform focused on simplifying the deployment of heat pumps for residential properties. The platform enhances the buying experience by connecting homeowners with qualified local installers, facilitating centralized lead generation and streamlined hardware procurement through direct marketplace integrations with manufacturers. This approach aims to improve and simplify the renovation process, allowing homeowners to efficiently manage projects such as heating and pump installation, roof replacement, and painting. By offering a comprehensive solution, DREM addresses the complexities often associated with energy-saving renovations.

BurnBot is a provider of fuel treatment services aimed at preventing destructive wildfires and enhancing vegetation management. The company utilizes advanced forestry and fire technology to offer systematic wildfire mitigation solutions. Its services include safe smoke containment and a modular system designed to create precise burn areas near homes and other valuable assets. By employing high-temperature ignition methods, BurnBot helps protect communities from the threats posed by wildfires while improving firebreaks and defensible spaces that safeguard infrastructure and natural resources.

Eigen Therapeutics is a biotechnology company dedicated to developing innovative therapies that enhance the detection and treatment of cancer. The company specializes in "priming" therapies, which help targeted treatments become more effective by addressing cancer heterogeneity and increasing the vulnerability of cancer cells, while simultaneously improving the resilience of healthy cells. Eigen is creating a high-throughput discovery platform that combines biology and engineering, utilizing proprietary machine learning algorithms to identify new drug classes and therapeutic approaches. This platform incorporates robotic systems, laboratory operations software, and machine learning analysis pipelines, all developed in-house. By focusing on combination therapeutics that improve efficacy and reduce toxicity, Eigen aims to provide physicians with access to novel treatments for patients with unmet medical needs, ultimately striving to enhance patient outcomes and save lives.

Rezo Therapeutics is a biotechnology company that focuses on developing precision therapeutics by mapping disease networks. Utilizing its proprietary Sequence to Systems to Drugs (SSD) platform, Rezo integrates various technologies, including proteomics, genetics, structural biology, chemistry, and bioinformatics, to create comprehensive molecular maps of diseases. This innovative approach enhances the identification of novel targets and therapies, particularly in oncology, where Rezo initially concentrates its efforts. The company aims to expand its therapeutic focus through collaborations and partnerships, positioning itself at the forefront of advancing treatment options across multiple disease areas.

Kaleidoscope is a collaborative, cloud-based research platform for organizing and tracking scientific activities.

Seabound specializes in carbon capture technology aimed at reducing CO2 emissions from cargo ships. The company has developed a system that can be integrated into existing ships, allowing these vessels to capture emissions directly from exhaust and convert the carbon dioxide into a solid form. This solid carbon can either be stored for future use or sold for various applications. Additionally, Seabound's technology can process carbon dioxide on land, producing limestone that can be sold or heated to generate calcium oxide for secondary recycling. By providing innovative solutions for both maritime and land-based carbon capture, Seabound contributes to the reduction of greenhouse gas emissions and pollution in the shipping industry.

Adaptyv Bio is focused on developing a protein engineering platform that leverages cell-free synthetic biology and high-throughput nanofluidics. The company’s technology aims to identify new antibodies for various diseases by bridging the gap between computational predictions and experimental validation. This innovative approach enhances the ability of healthcare providers to improve patient outcomes through more effective therapeutic options.

Reask is a science and technology company that specializes in natural hazard modeling and climate risk analytics. It develops software designed to connect catastrophe modeling with operational forecasting, offering solutions for real-time, post-event, and long-term assessments of weather-related risks. Utilizing machine learning and artificial intelligence, Reask provides comprehensive weather risk analysis and probabilistic trend forecasting. This enables organizations to better understand their exposure to global weather-related catastrophes and assess the risk levels within their asset portfolios. By focusing on global risk mapping and catastrophe risk analytics, Reask helps companies make informed decisions in managing their risk profiles.